| Home :: Biotechnology and Pharmaceuticals :: Cancer Research |
Aventis Cancer Vaccine Program Studying the possibilities of using an immunotherapeutic approach for melanoma, breast and colorectal and tumors. Includes results of clinical research, FAQ, contact form, and profile of research partners in Canada. http://www.cancervaccines.com/ InterGenetics Inc. Company with platform technology, called CombiSNiP, that genetically quantifies an individuals risk for development, and is involved in pharmacogenetics research on treating breast cancer. Includes corporate overview, directions and contacts in Oklahoma City. http://www.intergenetics.com/index1.html Karyon Offers products in angiogenesis and cell growth regulation, focusing on protected ligands that target specifically to sarcomas and melanomas. Includes research and technology overview, and information for investors in Helsinki, Finland. http://www.karyon.fi/ Cancer Survival Toolbox Introduction the mechanisms, with resources in oncology, vascular medicine and immunolgical disease, including possible therapies and links to related organizations, presented by Genentech, Inc. http://www.gene.com/gene/products/education/oncology/cst/ GeneSegue Focusing on the development of delivery systems to target solid tumors, such as prostate with nanoencapsulated biotherapeutics. Includes brief overview of concepts from Chaska, Min nesota. http://www.genesegues.com/ Biomoda, Inc. Offers products for diagnosis, imaging and treatment of tumors, especially in lung. Technologies in sputum sample and pap smear screening, certifying cell lines, inflammatory focus imaging, Cu-TCPP treatment in pre-clinical development at Albuquerque, New Mexico. http://www.biomoda.com/ PNP Therapeutics, Inc. Company developing gene therapy system, using the E. coli enzyme, purine nucleoside phosphorylase, to induce suicide in tumour cells. Includes technology background, research, patents, publications, key staff, and contacts in Birmingham, Al abama. http://www.pnptherapeutics.com/ |
